ProShare Advisors’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $53.9K | Sell |
24,706
-2,961
| -11% | -$6.46K | ﹤0.01% | 1982 |
|
2025
Q1 | $75.5K | Sell |
27,667
-6,795
| -20% | -$18.6K | ﹤0.01% | 1887 |
|
2024
Q4 | $143K | Buy |
34,462
+8,481
| +33% | +$35.3K | ﹤0.01% | 1982 |
|
2024
Q3 | $101K | Buy |
25,981
+7,828
| +43% | +$30.5K | ﹤0.01% | 1880 |
|
2024
Q2 | $71.2K | Sell |
18,153
-4,809
| -21% | -$18.9K | ﹤0.01% | 1705 |
|
2024
Q1 | $96.2K | Buy |
22,962
+1,878
| +9% | +$7.87K | ﹤0.01% | 1825 |
|
2023
Q4 | $99.1K | Buy |
21,084
+2,964
| +16% | +$13.9K | ﹤0.01% | 1782 |
|
2023
Q3 | $56.5K | Buy |
18,120
+87
| +0.5% | +$271 | ﹤0.01% | 1704 |
|
2023
Q2 | $82.8K | Buy |
18,033
+585
| +3% | +$2.69K | ﹤0.01% | 1724 |
|
2023
Q1 | $86.4K | Sell |
17,448
-2,187
| -11% | -$10.8K | ﹤0.01% | 1616 |
|
2022
Q4 | $107K | Buy |
19,635
+1,485
| +8% | +$8.11K | ﹤0.01% | 1640 |
|
2022
Q3 | $118K | Buy |
18,150
+467
| +3% | +$3.04K | ﹤0.01% | 1528 |
|
2022
Q2 | $83K | Sell |
17,683
-11,455
| -39% | -$53.8K | ﹤0.01% | 1639 |
|
2022
Q1 | $204K | Buy |
+29,138
| New | +$204K | ﹤0.01% | 1875 |
|